Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

NPA Petitions FDA to Acknowledge the Benefits of Manual, Non-chemical Approaches and the LiceMeister® Comb for the Care of Children with Head Lice
  • USA - English


News provided by

NATIONAL PEDICULOSIS ASSOCIATION

Feb 13, 2018, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Youtube
Youtube

As Mumcuoglu, et al. reported, “Diagnosis of louse infestation using a louse comb is four times more efficient than direct visual examination and twice as fast.

Post this

BOSTON (PRWEB) February 13, 2018 -- The National Pediculosis Association (NPA), a non-profit 501(c)(3) organization dedicated to protecting children and their environment from the misuse and abuse of prescription and over-the-counter pesticide treatments for lice and scabies, announced today that it has petitioned the Commissioner of the Food and Drug Administration (FDA) to amend its website and other educational collateral so that combing, in general, and the FDA-accepted 510(k) LiceMeister® comb, in particular, are presented as valid options for the management and treatment of the communicable disease pediculosis capitis (head lice).

The NPA’s petition is consistent with the FDA’s goal to empower consumers and patients to make informed and effective health decisions, as stated by Commissioner Scott Gottlieb, M.D. in his blog post, “Looking ahead: Some of FDA’s major policy goals for 2018.” Currently, the agency offers extensive information about brand name chemical methods that can be used to treat children with head lice, but mentions combing only briefly and generically, without sufficiently explaining the value of combing or that all lice combs are not equivalent.

The benefits of combing and the LiceMeister comb are well documented.

Since its inception in 1983, the NPA has advocated for combing to remove lice and nits. In 1997, the NPA developed the LiceMeister comb, which features elongated stainless metal teeth precisely fixed in a hygienically-sealed handle. The comb can be sterilized for safe and repeated use, and in 1998, it was “accepted” by the FDA as a 510(k) medical device (FDA K981250).

The indicated use of the LiceMeister is for “routine screening, early detection [and] removal of lice and their eggs,” which, when done thoroughly, effectively ends an infestation. That means the LiceMeister is a complete treatment that can either stand on its own as an alternative to pesticides and various chemicals or be used as a complement to other remedies.

When used routinely, combing allows parents to be the first to know their child is infested, discovering it early when there are fewer lice and nits to comb out. As reported by Mumcuoglu KY, et al, “Diagnosis of louse infestation using a louse comb is four times more efficient than direct visual examination and twice as fast. The direct visual examination technique underestimates active infestation and detects past, non-active infestations.” In fact, because combing is so effective for screening and treatment, it has spawned a cottage industry of lice and nit removal services and has become an accepted method for data collection in scientific research studies.

When used as a complete treatment, combing can meet the health and medical needs of those who are most vulnerable to pesticides, while reducing the use of potentially harmful chemicals.

For example, in 2000, the NPA partnered with the Sanitation District of Los Angeles County and the City of Los Angeles Bureau of Sanitation in the Lindane Usage Reduction Project, which identified lindane-based lice treatments as the source of lindane pollution in the Los Angeles water supply. The LiceMeister comb and NPA’s educational materials were critical features of this public health outreach project, which was recognized by the National Pollution Prevention Roundtable (NPPR) with its First Place Most Valuable Pollution Prevention (MVP2) Award honoring the most innovative and successful pollution prevention programs in the country. The project was credited as the first major program to convince physicians to change the medications they prescribe based on environmental concerns, and lindane was banned as a treatment for lice and scabies by California in 2002.

Subsequent research concluded that the elimination of lindane “was associated with a reduction in reported unintentional exposures, and did not adversely affect head lice [and scabies] treatment.” (The U.S. Environmental Protection Agency (EPA) cancelled lindane’s use in 2006. The FDA continues to allow the use of lindane for lice treatment although it requires a “black box” warning in the labeling to prescribers.)

In 2011, the LiceMeister raised the standard in lice combing tools around the world when it was featured as a lindane alternative at a global meeting of the Stockholm Convention. Since then, 179 countries prohibited lindane’s use entirely, including pharmaceutical use.

The FDA needs to update its website and other educational collateral.

Despite the numerous benefits of combing and the LiceMeister comb, the FDA’s website and educational collateral continue to prioritize pesticide or antibiotic formulations that put both the health of the person applying the treatment and the person receiving the treatment at risk. Pesticide exposure can lead to a myriad of serious medical and public health consequences, including but not limited to cancer, neurotoxicity, burning of the skin, breathing difficulties and behavior changes, along with pollution, lice resistance and chronic infestations that contribute to the communicability of lice to others. The recognition of pediculosis capitis as a public health issue has become increasingly important in recent years as schools relax their lice policies, allowing children to return to the classroom without requiring the removal of lice and nits.

Even in cases where chemical treatments are administered, the FDA recommends combing, but fails to help the consumer by not pointing out that combing tools can vary greatly. In its petition, the NPA requests that the information provided on combs and combing to be more specific given that the use of a quality comb can maximize treatment efficacy and minimize the overtreatment that can occur due to a panicked reaction to the presence of lice or as a desperate response to treatment failure.

“The FDA can do a better job of informing the public that combing is not only a valid treatment but an invaluable early detection tool,” said NPA's President Deborah Altschuler. “Updating the FDA’s website would help parents and others understand that the use of a quality comb to screen, detect and remove lice and nits (eggs) is a realistic, available and safe option for resolving an infestation.”

About The National Pediculosis Association:
Incorporated in 1983 and now in its 35th year, the National Pediculosis Association®, Inc. (NPA) is a 501(c)(3) non-profit volunteer organization, including scientific advisors dedicated to protecting children and their environment from the misuse and abuse of prescription and over-the-counter pesticide treatments for lice and scabies. Proceeds from the LiceMeister® comb allow the NPA to be self-sustaining and accomplish its mission. For more, please visit http://www.headlice.org. The NPA website offers free educational information and downloads and provides a special section of information and activities designed by kids for kids. http://www.headlice.org/kids/index.htm

Deborah Altschuler, NATIONAL PEDICULOSIS ASSOCIATION, http://headlice.org, +1 (617) 905-0176, [email protected]

Modal title

National Pediculosis Association Archives
National Pediculosis Association Archives
National Pediculosis Association's Petition to FDA 2018
View PDF
National Pediculosis Association's Petition to FDA 2018
National Pediculosis Association Archives National Pediculosis Association's Petition to FDA 2018

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.